Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hahne

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Science (New York, N.Y.)|November 22, 1996
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escapeM Hahne, D Rimoldi, M Schröter, et al.
The EMBO Journal|November 2, 2002
An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion proteinB Pradet-Balade, J P Medema, M López-Fraga, et al.
Physical Review Letters|August 29, 2014
Structural investigation of the (010) surface of the Al13 Fe4 catalystJ Ledieu, É Gaudry, L N Serkovic Loli, et al.
The Journal of Clinical Investigation|March 15, 1997
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?P Saas, P R Walker, M Hahne, et al.
Nature|July 10, 1997
Inhibition of death receptor signals by cellular FLIPM Irmler, M Thome, M Hahne, et al.
Nature Materials|June 12, 2012
Al13Fe4 as a low-cost alternative for palladium in heterogeneous hydrogenationM Armbrüster, K Kovnir, M Friedrich, et al.
The Journal of Experimental Medicine|September 22, 1998
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growthM Hahne, T Kataoka, M Schröter, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2001
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumorsJ P Medema, J de Jong, L T Peltenburg, et al.
Cell Death and Differentiation|June 19, 2012
The TNF family member APRIL promotes colorectal tumorigenesisV Lascano, L F Zabalegui, K Cameron, et al.
Immunity|January 1, 1997
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)J L Bodmer, K Burns, P Schneider, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Science (New York, N.Y.)|November 22, 1996
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escapeM Hahne, D Rimoldi, M Schröter, et al.
The EMBO Journal|November 2, 2002
An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion proteinB Pradet-Balade, J P Medema, M López-Fraga, et al.
Physical Review Letters|August 29, 2014
Structural investigation of the (010) surface of the Al13 Fe4 catalystJ Ledieu, É Gaudry, L N Serkovic Loli, et al.
The Journal of Clinical Investigation|March 15, 1997
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?P Saas, P R Walker, M Hahne, et al.
Nature|July 10, 1997
Inhibition of death receptor signals by cellular FLIPM Irmler, M Thome, M Hahne, et al.
Nature Materials|June 12, 2012
Al13Fe4 as a low-cost alternative for palladium in heterogeneous hydrogenationM Armbrüster, K Kovnir, M Friedrich, et al.
The Journal of Experimental Medicine|September 22, 1998
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growthM Hahne, T Kataoka, M Schröter, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2001
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumorsJ P Medema, J de Jong, L T Peltenburg, et al.
Cell Death and Differentiation|June 19, 2012
The TNF family member APRIL promotes colorectal tumorigenesisV Lascano, L F Zabalegui, K Cameron, et al.
Immunity|January 1, 1997
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)J L Bodmer, K Burns, P Schneider, et al.
Pageof 10